BioSpace News Archive

Lenzilumab among the promising agents selected for ACTIV program from pool of approximately 400 candidate agents

Laboratory developed tests play a vital role in getting patients accurate diagnoses and effective care, and at no time has their importance been clearer than during the current pandemic.

On World Thrombosis Day, Thrombosis Canada is warning Canadians that it is more critical now than ever before to learn the signs and symptoms of thrombosis, or blood clots. With new COVID-19 cases growing, there is an increased risk of some patients developing blood clots in the veins that cause leg clots (called deep vein thrombosis

This renewal extends Karmanos’ 42-year history of prestigious designation as one of only 51 Comprehensive Cancer Centers in the nation [13-October-2020] DETROIT , Oct. 13, 2020 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute is pleased to announce that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious

Calviri, Inc., a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for Arizona State University (“ASU”), granted Calviri an exclusive license to ASU’s Immunosignature patent portfolio. The portfolio consists of multiple granted and pending patents for the use and optimization of immunosignatures as an antibody-based diagnostic platform in t

Dozens of concerned healthcare advocates from across the northeast region protest AstraZeneca, one of five U.S. based pharmaceutical companies that have cut back on the number of drugs they provide through the 340B federal drug discount program.

Soin Neuroscience Inc. (SNI), a biotech startup based in Dayton, Ohio , has developed a novel implantable sacral nerve stimulator to treat bladder incontinence. As many as 46 million Americans 40 years of age or older have reported symptoms of urinary incontinence often due to a condition known as overactive bladder, according to th

Physicians’ Education Resource® Brings Psychiatric Disorders to the Forefront During Evolving Times at Annual Psychiatric Times® World CME Conference™ The live, interactive CME virtual conference features premiere access to world-leading psychiatric experts delivering evidence-based presentations on crucial psychiatric topics in 2020

miR Scientific, LLC , a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that it has received Breakthrough Device Designation by the U.S Food & Drug Administration for its miR Sentinel™ PCC4 Assay (m

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI).